지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Gonadotropin releasing hormone antagonist administration for treatment of early type severe ovarian hyperstimulation syndrome: a case series
Obstetrics & Gynecology Science
2017 .01
The use of gonadotropin-releasing hormone antagonist post-ovulation trigger in ovarian hyperstimulation syndrome
Clinical and experimental reproductive medicine : CERM
2017 .01
Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients
Journal of Breast Cancer
2015 .01
Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy
Journal of Breast Cancer
2017 .01
Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?
Obstetrics & Gynecology Science
2021 .01
Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist
Obstetrics & Gynecology Science
2017 .01
Serum Cholesterol Level Changes during Gonadotropin-Releasing Hormone-Agonist Therapy in Premenopausal Female Patients with Breast Cancer
대한폐경학회지
2024 .08
Reduction of the cetrorelix dose in a multiple-dose antagonist protocol and its impact on pregnancy rate and affordability: A randomized controlled multicenter study
Clinical and experimental reproductive medicine : CERM
2017 .01
A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer
Journal of Gynecologic Oncology
2019 .01
Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment
Clinical and experimental reproductive medicine : CERM
2016 .01
Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?
Annals of Surgical Treatment and Research
2023 .07
Efficacy of corifollitropin alfa followed by recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist protocol for Korean women undergoing assisted reproduction
Clinical and experimental reproductive medicine : CERM
2015 .01
Combination of a Rapidly Penetrating Agonist and a Slowly Penetrating Antagonist Affords Agonist Action of Limited Duration at the Cellular Level
Biomolecules & Therapeutics(구 응용약물학회지)
2019 .01
A high response to controlled ovarian stimulation induces premature luteinization with a negative impact on pregnancy outcomes in a gonadotropin-releasing hormone antagonist cycle
Clinical and experimental reproductive medicine : CERM
2015 .01
Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report
Obstetrics & Gynecology Science
2019 .01
Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment
Journal of Korean Medical Science
2017 .01
Detection of androgenic agonist and antagonist activity using transactivation in vitro assay with metabolizing system
환경독성보건학회 심포지엄 및 학술대회
2022 .10
Evaluation of infertility efficacy of the E. coli expressed STF2-GnRH vaccine in male cats
Journal of Veterinary Science
2019 .05
Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
Annals of Dermatology
2019 .01
Gonadotropin-releasing hormone stimulation test and diagnostic cutoff in precocious puberty: a mini review
Annals of Pediatirc Endocrinology & Metabolism
2020 .01
0